Crohn's disease management after intestinal resection: a randomised trial
- 23 December 2014
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 385 (9976), 1406-1417
- https://doi.org/10.1016/s0140-6736(14)61908-5
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohnʼs diseaseInflammatory Bowel Diseases, 2012
- Postoperative recurrence of Crohn’s disease: impact of endoscopic monitoring and treatment step‐upColorectal Disease, 2012
- Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegolGut, 2012
- Infliximab, Azathioprine, or Combination Therapy for Crohn's DiseaseThe New England Journal of Medicine, 2010
- Recurrence of Crohn's Disease After Ileocolic Resection Is Not Affected by Anastomotic TypeDiseases of the Colon & Rectum, 2009
- Therapy of Metronidazole With Azathioprine to Prevent Postoperative Recurrence of Crohn's Disease: A Controlled Randomized TrialGastroenterology, 2008
- Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based CohortGastroenterology, 2007
- Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's diseaseGastrointestinal Endoscopy, 2006
- Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms.Gut, 1992
- Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery.Gut, 1984